"Urology Practice active in both Memphis and North Mississippi"

During the past decade, Southeast Urology Network conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southeast Urology Network" are "Cystitis, Interstitial" (1 trials), "Fractures" (1 trials), "Osteoporosis" (1 trials), "Preneoplastic Conditions" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Southeast Urology Network" in a lesser frequency.

Most popular intervention types in "Southeast Urology Network" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Tanezumab" (1 trials), "Toremifene 20 mg" (1 trials), "Toremifene Citrate" (1 trials) and "solifenacin succinate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Urology Network" are 3 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Southeast Urology Network". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Southeast Urology Network, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Urology Network, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".